Loading…
20,252 grants found
Showing 1,401 – 1,420 of 20,252 grants
Targeting the prostate-specific membrane antigen (PSMA) with small molecules for imaging and therapy of prostate cancer (PC) has revitalized the field of nuclear medicine. Few targ...
PROJECT SUMMARY Pancreatic cancer has a dismal average life expectancy of around six months, in large part due to the marked immunosuppression surrounding the tumor preventing an a...
ABSTRACT The recent development of T cell-based cancer immunotherapies, including checkpoint blockade (anti-PD-1, anti-CTLA-4 and others) or adoptive T cell therapy (ACT) using mod...
PROJECT SUMMARY Given the important roles of tumor suppressors and oncogenes in metabolic reprogramming, there is significant translational potential in identifying and understandi...
PROJECT SUMMARY Estrogen receptor (ER) signaling is the main driver of tumorigenesis in ER+ breast cancers by inducing proliferation and survival through genomic and non-genomic me...
PROJECT SUMMARY We request partial funding for the Midwest Tumor Microenvironment Meeting to be held at the University of Wisconsin-Madison Pyle Center in Madison, WI on May 20-22,...
PROJECT SUMMARY (ABSTRACT) An evolving concept that contributes to our understanding of resistance to androgen deprivation therapy (ADT) or androgen receptor (AR) antagonists in ad...
PROJECT SUMMARY/ABSTRACT Cancer evolution driven by DNA-mutating APOBEC enzymes (apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like), and the emergence of resistance...
Project Summary/Abstract Estrogen receptor positive (ER+) breast cancer (BC) accounts for the majority of all diagnosed BC for women in the United States. While traditional antihor...
PROJECT SUMMARY: Myeloid malignancy is characterized by the acquisition of mutations in a stereotyped order with distinct patterns of cooperating mutations. Mutations in genes that...
SUMMARY There is a higher incidence and mortality of colorectal cancer (CRC) in individuals self-identifying as Black race compared to all other races and ethnicities in the US. Pr...
PROJECT SUMMARY Androgen receptor (AR) signaling is a major driver of prostate cancer (PCa) progression. Persistent activation of AR due to aberrant intratumoral androgen synthesis...
We propose to study extracellular vesicles (EVs) as novel mediators of the pathogenesis of radiation cystitis (RC), which affects approximately 15% of prostate cancer (PCa) patient...
SUMMARY Transgender (TG) men (assigned female at birth) and TG women (assigned male at birth) comprise a vulnerable population whose health is largely understudied. Approximately 7...
PROJECT SUMMARY Cancer-related cognitive impairment (CRCI) represents an important clinical issue affecting up to 75% of people before, during, and after diagnosis and treatment. U...
Microbiome impacts cancer development and therapeutic efficacy. In addition to the guts, microbes reside in different tissues influencing the pathophysiology of the tissue microenv...
SUMMARY/ ABSTRACT Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with a 5-year survival rate of only ~12%. Therefore, there is a critical unmet need for new treatm...
Project Summary/Abstract Breast surgeons have been highly successful at deimplementing some low-value surgical care but less successful at deimplementing care that is preference-se...
SUMMARY The ability of cancer cells to acquire resistance to anticancer drugs, resulting in eventual treatment failure, is one of the most challenging problems in cancer therapy. O...
PROJECT SUMMARY/ABSTRACT Treating KRAS mutant lung adenocarcinoma (LUAD) remains a major challenge for clinical oncology. Approximately 20% of KRAS mutant LUAD tumors carry loss-of...